Neogenomics Inc (NEO.OQ) Key Developments | Reuters.com
Edition:
United States

Analyst Research

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : New Constructs, LLC
$25.00
Provider : Stock Traders Daily
$20.00
Provider : ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Neogenomics announces closing of recent equity offering


Friday, 22 Aug 2014 07:00am EDT 

Neogenomics Inc:Says it has closed on the public offering of an additional 1.05 mln shares of common stock at an offering price of $4.60 per share as a result of the exercise in full of the underwriters' over-allotment option.Total gross proceeds of the offering, including the exercise in full of the over-allotment option were about $37.0 mln from the sale of a total of 8.05 mln common shares.Plans to use the net proceeds for working capital, capital expenditures and for general corporate purposes.William Blair & Company, L.L.C. acted as the sole book-running manager and Craig-Hallum Capital Group LLC acted as co-lead manager for the offering.Stephens Inc., Roth Capital Partners, LLC, Sidoti & Company, LLC and Dawson James Securities, Inc. served as co-managers for the offering. 

Company Quote

8.01
0.04 +0.50%
3:03pm EDT